Published in Prostate on May 15, 1999
Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell (2009) 5.74
DNA hypomethylation in cancer cells. Epigenomics (2009) 3.71
Tumour class prediction and discovery by microarray-based DNA methylation analysis. Nucleic Acids Res (2002) 2.34
DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Br J Cancer (1999) 1.86
Human transposon tectonics. Cell (2012) 1.81
GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Am J Pathol (2001) 1.60
Comparative methylome analysis of benign and malignant peripheral nerve sheath tumors. Genome Res (2011) 1.60
Epigenetic alterations in human prostate cancers. Endocrinology (2009) 1.55
Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors. Oncogene (2006) 1.46
Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation. Br J Cancer (2004) 1.41
L1 retrotransposons in human cancers. J Biomed Biotechnol (2006) 1.34
Long interspersed nuclear element-1 hypomethylation in cancer: biology and clinical applications. Clin Epigenetics (2011) 1.26
Line region hypomethylation is associated with lifestyle and differs by human papillomavirus status in head and neck squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev (2008) 1.25
L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas. Mol Cancer (2004) 1.20
Repetitive sequence environment distinguishes housekeeping genes. Gene (2006) 1.12
Association of nuclear localization of a long interspersed nuclear element-1 protein in breast tumors with poor prognostic outcomes. Genes Cancer (2010) 1.12
Epigenetics of prostate cancer: beyond DNA methylation. J Cell Mol Med (2006) 1.12
Reactivation of L1 retrotransposon by benzo(a)pyrene involves complex genetic and epigenetic regulation. Epigenetics (2011) 1.03
Both hypomethylation and hypermethylation in a 0.2-kb region of a DNA repeat in cancer. Mol Cancer Res (2005) 1.02
Dietary factors and epigenetic regulation for prostate cancer prevention. Adv Nutr (2011) 1.00
Promoter hypermethylation in prostate cancer. Cancer Control (2010) 0.99
Aberrant DNA methylation and prostate cancer. Curr Genomics (2011) 0.98
Mobilizing diversity: transposable element insertions in genetic variation and disease. Mob DNA (2010) 0.93
Epigenetics in prostate cancer. Prostate Cancer (2011) 0.92
GSTP1 DNA methylation and expression status is indicative of 5-aza-2'-deoxycytidine efficacy in human prostate cancer cells. PLoS One (2011) 0.89
DNA methylation in promoter region as biomarkers in prostate cancer. Methods Mol Biol (2012) 0.88
Epigenetics in bladder cancer. Int J Clin Oncol (2008) 0.84
Zebularine partially reverses GST methylation in prostate cancer cells and restores sensitivity to the DNA minor groove binder brostallicin. Epigenetics (2013) 0.83
Activation of innate anti-viral immune response genes in symptomatic benign prostatic hyperplasia. Genes Immun (2012) 0.82
Retrotransposon-encoded reverse transcriptase in the genesis, progression and cellular plasticity of human cancer. Cancers (Basel) (2011) 0.81
Mobilization of LINE-1 in irradiated mammary gland tissue may potentially contribute to low dose radiation-induced genomic instability. Genes Cancer (2015) 0.81
Epigenetic regulation of prostate cancer. Clin Epigenetics (2011) 0.79
Pathological and evolutionary implications of retroviruses as mobile genetic elements. Genes (Basel) (2013) 0.77
Role of diet in prostate cancer: the epigenetic link. Oncogene (2014) 0.76
LINE-1 methylation status in prostate cancer and non-neoplastic tissue adjacent to tumor in association with mortality. Epigenetics (2016) 0.75
DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Br J Cancer (1999) 1.86
[Syrian hamsters as vectors of lymphocytic choriomeningitis]. Dtsch Med Wochenschr (1972) 1.56
Formation of 8-hydroxy(deoxy)guanosine and generation of strand breaks at guanine residues in DNA by singlet oxygen. Biochemistry (1991) 1.53
[Tick born meningopolyneuritis (Garin-Bujadoux, Bannwarth) (author's transl)]. Fortschr Neurol Psychiatr Grenzgeb (1973) 1.45
Microsatellite instability analysis: a multicenter study for reliability and quality control. Cancer Res (1997) 1.43
Antibody responses to the three genomic groups of Borrelia burgdorferi in European Lyme borreliosis. J Infect Dis (1994) 1.41
Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation. Br J Cancer (2004) 1.41
Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis. J Infect Dis (1990) 1.36
Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors. Cancer Res (1991) 1.28
[Progressive Borrelia encephalomyelitis. Chronic manifestation of erythema chronicum migrans disease of the nervous system]. Dtsch Med Wochenschr (1985) 1.27
Dynamic expression pattern of the myc protooncogene in midgestation mouse embryos. Science (1989) 1.24
Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma. Cancer Res (1996) 1.24
[Spirochete etiology of erythema chronicum migrans disease]. Dtsch Med Wochenschr (1984) 1.23
Enhancement of reporter gene de novo methylation by DNA fragments from the alpha-fetoprotein control region. J Biol Chem (1994) 1.13
Multiple sclerosis-associated agent: transmission to animals and some properties of the agent. Infect Immun (1975) 1.13
Effects of WNT/beta-catenin pathway activation on signaling through T-cell factor and androgen receptor in prostate cancer cell lines. Int J Oncol (2005) 1.12
[Erythema chronicum migrans with arthritis (author's transl)]. Dtsch Med Wochenschr (1980) 1.12
Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinoma. Endocr Relat Cancer (2006) 1.12
[Chronic erythema migrans and tick-transmitted meningopolyneuritis (Garin-Bujadoux-Bannwarth): Borrelia infections?]. Dtsch Med Wochenschr (1983) 1.11
Collagens in the liver extracellular matrix bind hepatocyte growth factor. Gastroenterology (1998) 1.10
Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-[(18)F]-2-deoxy-D-glucose. Eur Urol (1999) 1.09
A comparative analysis of N-myc and c-myc expression and cellular proliferation in mouse organogenesis. Mech Dev (1991) 1.08
Chromosomal imbalances in gastric cancer. Correlation with histologic subtypes and tumor progression. Am J Clin Pathol (2001) 1.08
Delineation of the 6p22 amplification unit in urinary bladder carcinoma cell lines. Cancer Res (2000) 1.05
Transcriptional regulation of the human LINE-1 retrotransposon L1.2B. Mol Genet Genomics (2003) 1.04
Nitric oxide-mediated inhibition of androgen receptor activity: possible implications for prostate cancer progression. Oncogene (2006) 1.04
Multiple sclerosis-associated agent: neutralization of the agent by human sera. Infect Immun (1975) 1.04
Undulin, an extracellular matrix glycoprotein associated with collagen fibrils. J Biol Chem (1990) 1.04
Interobserver reproducibility of Gleason grading: evaluation using prostate cancer tissue microarrays. J Cancer Res Clin Oncol (2008) 1.03
Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers. J Surg Oncol (2007) 1.03
Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue. J Urol (1995) 1.03
Collagen VI regulates normal and transformed mesenchymal cell proliferation in vitro. Exp Cell Res (1996) 1.02
[Prenatal infection with the virus of lymphocytic choriomeningitis: report of two cases (author's transl)]. Dtsch Med Wochenschr (1974) 1.02
Fibroblast growth factors and their receptors in urological cancers: basic research and clinical implications. Eur Urol (2003) 1.01
Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch Toxicol (2000) 1.01
Tick-borne meningopolyneuritis (Garin-Bujadoux, Bannwarth). Yale J Biol Med (1985) 1.01
E-cadherin involved in inactivation of WNT/beta-catenin signalling in urothelial carcinoma and normal urothelial cells. Br J Cancer (2003) 1.01
Lowered amounts of the tissue-specific transcription factor LFB1 (HNF1) correlate with decreased levels of glutathione S-transferase alpha messenger RNA in human renal cell carcinoma. Cancer Res (1994) 1.00
Correlation between retinoblastoma gene expression and differentiation in human testicular tumors. Proc Natl Acad Sci U S A (1991) 1.00
Expression of NAD(P)H:quinone oxidoreductase and glutathione S-transferases alpha and pi in human renal cell carcinoma and in kidney cancer-derived cell lines. Carcinogenesis (1994) 1.00
Ixodes ricinus spirochete and European erythema chronicum migrans disease. Yale J Biol Med (1985) 0.98
Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma. Cancer Res (1990) 0.98
Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors. Cancer Res (2001) 0.97
Differential effects of Nucleostemin suppression on cell cycle arrest and apoptosis in the bladder cancer cell lines 5637 and SW1710. Cell Prolif (2009) 0.97
Impact of diagnosis of diabetes on health-related quality of life among high risk individuals: the Diabetes Prevention Program outcomes study. Qual Life Res (2013) 0.96
DKC1 overexpression associated with prostate cancer progression. Br J Cancer (2009) 0.95
Loss of heterozygosity at the NAD(P)H: quinone oxidoreductase locus associated with increased resistance against mitomycin C in a human bladder carcinoma cell line. Biol Chem Hoppe Seyler (1994) 0.95
Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder. Br J Cancer (2001) 0.95
P-element inserts in transgenic flies: a cautionary tale. Heredity (Edinb) (1997) 0.95
Cerebrospinal fluid virus antibodies. A diagnostic indicator for multiple sclerosis? J Neurol Sci (1985) 0.94
Disruption of the FA/BRCA pathway in bladder cancer. Cytogenet Genome Res (2007) 0.94
[Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors]. Urologe A (1998) 0.94
DNA methylation and the mechanisms of CDKN2A inactivation in transitional cell carcinoma of the urinary bladder. Lab Invest (2000) 0.93
Collagens serve as an extracellular store of bioactive interleukin 2. J Biol Chem (2000) 0.93
Eyach--an arthropod-borne virus related to Colorado tick fever virus in the Federal Republic of Germany. Acta Virol (1976) 0.91
Over-expression and amplification of the c-myc gene in human urothelial carcinoma. Int J Cancer (1999) 0.91
[Meningopolyneuritis (Garin-Bujadoux, Bannwarth) erythema chronicum migrans disease of the nervous system transmitted by ticks]. Fortschr Neurol Psychiatr (1985) 0.90
Bacteremia during extracorporeal shock wave lithotripsy of renal calculi. J Urol (1991) 0.90
Fast and efficient purification of yeast plasma membranes using cationic silica microbeads. Biochim Biophys Acta (1983) 0.90
Inactivation of tumor suppressor genes and deregulation of the c-myc gene in urothelial cancer cell lines. Urol Res (1995) 0.90
Polymorphic methyl group metabolism genes in patients with transitional cell carcinoma of the urinary bladder. Mutat Res (2001) 0.90
Stem cells in the biology of normal urothelium and urothelial carcinoma. Neoplasma (2012) 0.89
Pharmacokinetics and pharmacodynamics of the ace inhibitor benazepril hydrochloride in the elderly. Eur J Clin Pharmacol (1990) 0.89
[Spread of the lymphocytic choriomeningitis virus among West German mice. I. Investigations mostly on domestic mice (Mus musculus)]. Zentralbl Bakteriol Orig (1964) 0.89
Natural and acquired epidermal autoantibodies in man. J Immunol (1974) 0.88
Loss of HNF1alpha function in human renal cell carcinoma: frequent mutations in the VHL gene but not the HNF1alpha gene. Mol Carcinog (1999) 0.88
Pharmacokinetics of a new angiotensin-converting enzyme inhibitor, benazepril hydrochloride, in special populations. Am Heart J (1989) 0.88
Novel mutations of the von hippel-lindau tumor-suppressor gene and rare DNA hypermethylation in renal-cell carcinoma cell lines of the clear-cell type. Int J Cancer (2000) 0.88
Clinical outcome of patients with lymph node positive prostate cancer after radical prostatectomy versus androgen deprivation. Eur Urol (2002) 0.87
Hypermethylation of the tumor necrosis factor receptor superfamily 6 (APT1, Fas, CD95/Apo-1) gene promoter at rel/nuclear factor kappaB sites in prostatic carcinoma. Mol Carcinog (2001) 0.87
The androgen receptor in hormone-refractory prostate cancer: relevance of different mechanisms of androgen receptor signaling (Review). Int J Oncol (2003) 0.86
Expression of cell-cycle regulatory proteins cyclin D1, cyclin E, and their inhibitor p21 WAF1/CIP1 in gastric cancer. J Pathol (1999) 0.86
[Neutralizing serum antibodies against the Central European encephalitis virus in the rural population of the Federal Republic of Germany]. Dtsch Med Wochenschr (1968) 0.86
[Distribution of the lymphocytic choriomeningitis virus in an endemic area]. Dtsch Med Wochenschr (1968) 0.86
Phenol sulphotransferase SULT1A1 polymorphism in prostate cancer: lack of association. Arch Toxicol (2000) 0.86
High-intensity focused ultrasound (HIFU) in the treatment of benign prostatic hyperplasia (BPH). Keio J Med (1995) 0.85
FHIT gene in gastric cancer: association with tumour progression and prognosis. J Pathol (1999) 0.85
Coexpression of the c-myc protooncogene with alpha-fetoprotein and albumin in fetal mouse liver. Differentiation (1990) 0.85
Methyl group metabolism gene polymorphisms and susceptibility to prostatic carcinoma. Prostate (2000) 0.85
c-myc in bladder cancer. Clinical findings and analysis of mechanism. Urol Res (1997) 0.84
Urological treatment and clinical course of BK polyomavirus-associated hemorrhagic cystitis in children after bone marrow transplantation. Eur Urol (1999) 0.84
The demonstration of locally synthesized herpes simplex IgG antibodies in CSF by a Sepharose 4B linked enzyme immunoassay. J Neuroimmunol (1982) 0.84
Interaction of human malignant melanoma (ST-ML-12) tumor spheroids with endothelial cell monolayers. Damage to endothelium by oxygen-derived free radicals. Am J Pathol (1992) 0.83
Locally synthesized antibodies in cerebrospinal fluid of patients with AIDS. J Neurol (1986) 0.83
Thirteen years follow-up after radical transsternal thymectomy for myasthenia gravis. Do short-term results predict long-term outcome? Eur J Cardiothorac Surg (2002) 0.83
Dexamethasone restores hormonal inducibility of ornithine decarboxylase in primary cultures of rat hepatocytes. Eur J Biochem (1985) 0.83
Early diagnosis and treatment of herpes simplex encephalitis. J Neurol (1985) 0.83
Frequent and heterogeneous expression of cyclin-dependent kinase inhibitor WAF1/p21 protein and mRNA in urothelial carcinoma. Br J Cancer (1998) 0.83
Classic and modern prognostic indicators in renal cell carcinoma. Review of the literature. Urol Int (1991) 0.83
P53 accumulation in precursor lesions and early stages of bladder cancer. World J Urol (1994) 0.82
The effect of father absence on the psychiatric hospitalization of Navy children. Mil Med (1995) 0.82
[The infection rate of the rural population in the Federal Republic of Germany with the lymphocytic choriomeningitis virus]. Zentralbl Bakteriol Orig (1970) 0.82